摘要
目的：探讨分析胰漶匕肽原醇加雷公藤多苷治疗慢性肾小球肾炎的临床疗效。方法：选取我陇2011年l-12月闻收治的确诊为慢性肾小球肾炎患者40例．在征得患者及家属罔它的情况下分为观察组和对照组，每组患者各20例。观察蛆患者蛤予胰漱肽原肆加雷公藤多苷治疗。对照组患者培予雷公藤多瞽治疗，疗程均为90d。观察两组患者治疗后的疗效，比较两组患者治疗前与治疗后的24h尿蛋白（Pr24h）、血清总蛋白（STP）、血清白蛋白（ALB）、血策可溶性内皮细胞蛋白C受体（sEPCR）、血浆p-选择素（sPs）水平。蛄秉：治疗后两组在Pr24h、STp、ALB、sEPCR、sPs方面均有明显变化。观察组明显优于对照组，两组比较有显著盖并．P〈0．05．盖异有统计学意义。蛄论：胰激肽原酶加雷公藤多苷治疗慢性肾小球肾炎的临床疗灶显著，值得临床推广。
Objective： To investigate and analysis the clinical efficacy of chronic glomerulonephritis treated by pancreatic kallikrein ＋ TWP. Methods： 40 Cases chronic glomerulonephritis patiants from January to December 2011 in our hospital were treated, with the approval of patients and their families consent, were divided into observation group and control group, each 20 cases. The observation group were treated with pancreatic kallikrein ＋ TWP, the control group were given TWP treatment, a course of 90 d. The clinical efficacy were observed after treatment, and 24 h urine protein （Pr24h）, serum total protein （STP）, serum albumin （ALB）, plasma soluble endothelial protein C receptor （sEPCR）, plasma P-selectin （sPs） levels were compared between two groups before and after treatment. Results： After treatment, the Pr24h, STP, ALB, sEPCR, sPs of the observation group had changes, there were significant differences between the two groups, P〈0.05, the difference was statistically significant. Conclusion： Pancreatic kallikrein ＋ TWP treatment chronic glomerulonephritis has significant clinical effect, is worthy of promotion.
出处
《实用中西医结合临床》
2014年第2期9-10,共2页
Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
